What is the Difference Between Biotech versus Medtech?
Post written by: BioTech Health X
You May Also Like
Repertoire Immune Medicines Enters Collaboration with Yale to Research Multiple Sclerosis Novel Antigen Discovery & T Cell Receptors
The collaboration between Repertoire and Yale seeks to identify novel antigenic reactivity of T cells in patients with…
Brickell Biotech Regains Nasdaq Compliance Meeting Minimum Bid Price Requirement
Table of Contents Hide About BrickellWhat This Means for Brickell Biotech ShareholdersUnderstanding Nasdaq Minimum Bid Price RequirementWhy Nasdaq…
Aerobiotix Announces Raise of $25M Growth Equity Financing Led by Healthcare Investment Firm Vivo Capital
Aerobiotix, a pioneer in airborne infection control products that provide real-time, in room solutions for hospitals, ASCs, long…
Virios Therapeutics Stock Plunges 70% on Fibromyalgia Clinical Trial Failure Results
Table of Contents Hide FORTRESS Fibromyalgia Clinical Trial OverviewVirios Therapeutics Trial FailureIMC-1 Safety & EfficacyVirios Therapeutics Executive Commentary…
Merck Announces Failure in Keytruda Head and Neck Cancer Phase 3 Clinical Trial
Today Merck & Co. (NYSE: MRK) announced that Keytruda has failed the Phase 3 clinical trial KEYNOTE-412 evaluating…
PharmaCyte Biotech Announces Uplist to Nasdaq Capital Market and Public Offering
Biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCBD), a company concentrated on creating cellular therapies for cancer cells and…